SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-22-000055
Filing Date
2022-11-04
Accepted
2022-11-03 19:24:04
Documents
83
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20220930.htm   iXBRL 10-Q 2783905
2 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_2022930xq3.htm EX-31 20001
3 SECTION 1350 CERTIFICATIONS amgn-ex32_2022930xq3.htm EX-32 9664
4 FIRST AMENDMENT TO SOURCING AND SUPPLY AGREEMENT BETWEEN AMGEN AND DAVITA exhibit1036-firstamendment.htm EX-10.36 200390
  Complete submission text file 0000318154-22-000055.txt   11400155

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20220930.xsd EX-101.SCH 58151
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20220930_cal.xml EX-101.CAL 70423
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20220930_def.xml EX-101.DEF 356162
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20220930_lab.xml EX-101.LAB 683724
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20220930_pre.xml EX-101.PRE 488448
77 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20220930_htm.xml XML 2398063
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 221359771
SIC: 2836 Biological Products, (No Diagnostic Substances)